Development and validation of a high-per
โ
Federica Sala; Renzo Bagnati; Valeria Livi; Roberta Cereda; Maurizio D'Incalci;
๐
Article
๐
2011
๐
John Wiley and Sons
๐
English
โ 195 KB
Eโ3810, 6โ[[7โ[(1โaminocyclopropyl)methoxy]โ6โmethoxyโ4โquinolyl]oxy]โ__N__โmethylโnaphthaleneโ1โcarboxamide, is a novel, potent, dual inhibitor of vascular endothelial growth factor and fibroblast growth factor receptors with antiangiogenic properties, now under early clinical evaluation as an anti